Cargando…
Aptamer Cell-Based Selection: Overview and Advances
Aptamers are high affinity single-stranded DNA/RNA molecules, produced by a combinatorial procedure named SELEX (Systematic Evolution of Ligands by Exponential enrichment), that are emerging as promising diagnostic and therapeutic tools. Among selection strategies, procedures using living cells as c...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618307/ https://www.ncbi.nlm.nih.gov/pubmed/28805744 http://dx.doi.org/10.3390/biomedicines5030049 |
_version_ | 1783267156804239360 |
---|---|
author | Catuogno, Silvia Esposito, Carla Lucia |
author_facet | Catuogno, Silvia Esposito, Carla Lucia |
author_sort | Catuogno, Silvia |
collection | PubMed |
description | Aptamers are high affinity single-stranded DNA/RNA molecules, produced by a combinatorial procedure named SELEX (Systematic Evolution of Ligands by Exponential enrichment), that are emerging as promising diagnostic and therapeutic tools. Among selection strategies, procedures using living cells as complex targets (referred as “cell-SELEX”) have been developed as an effective mean to generate aptamers for heavily modified cell surface proteins, assuring the binding of the target in its native conformation. Here we give an up-to-date overview on cell-SELEX technology, discussing the most recent advances with a particular focus on cancer cell targeting. Examples of the different protocol applications and post-SELEX strategies will be briefly outlined. |
format | Online Article Text |
id | pubmed-5618307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-56183072017-09-29 Aptamer Cell-Based Selection: Overview and Advances Catuogno, Silvia Esposito, Carla Lucia Biomedicines Review Aptamers are high affinity single-stranded DNA/RNA molecules, produced by a combinatorial procedure named SELEX (Systematic Evolution of Ligands by Exponential enrichment), that are emerging as promising diagnostic and therapeutic tools. Among selection strategies, procedures using living cells as complex targets (referred as “cell-SELEX”) have been developed as an effective mean to generate aptamers for heavily modified cell surface proteins, assuring the binding of the target in its native conformation. Here we give an up-to-date overview on cell-SELEX technology, discussing the most recent advances with a particular focus on cancer cell targeting. Examples of the different protocol applications and post-SELEX strategies will be briefly outlined. MDPI 2017-08-14 /pmc/articles/PMC5618307/ /pubmed/28805744 http://dx.doi.org/10.3390/biomedicines5030049 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Catuogno, Silvia Esposito, Carla Lucia Aptamer Cell-Based Selection: Overview and Advances |
title | Aptamer Cell-Based Selection: Overview and Advances |
title_full | Aptamer Cell-Based Selection: Overview and Advances |
title_fullStr | Aptamer Cell-Based Selection: Overview and Advances |
title_full_unstemmed | Aptamer Cell-Based Selection: Overview and Advances |
title_short | Aptamer Cell-Based Selection: Overview and Advances |
title_sort | aptamer cell-based selection: overview and advances |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618307/ https://www.ncbi.nlm.nih.gov/pubmed/28805744 http://dx.doi.org/10.3390/biomedicines5030049 |
work_keys_str_mv | AT catuognosilvia aptamercellbasedselectionoverviewandadvances AT espositocarlalucia aptamercellbasedselectionoverviewandadvances |